Defining the clinical phenotype of COVID-19 in children
- PMID: 33236440
- PMCID: PMC7753524
- DOI: 10.1111/pai.13355
Defining the clinical phenotype of COVID-19 in children
Abstract
On January 7, 2020, a novel coronavirus (SARS-CoV-2) was identified as the causative agent of a cluster of pneumonia of unknown origin detected in Wuhan City by Chinese authorities. Since SARS-CoV-2 discovery, the corresponding disease (COVID-19) has rapidly expanded throughout the globe, making as a consequence the World Health Organization (WHO) declaring a pandemic. As of May 19, 2020, over 4.806.299 cases of COVID-19 had been confirmed worldwide, with more than 318.599 deaths.
Keywords: COVID-19; Italy; SARS-CoV-2; children.
© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no competing interests to declare.
References
-
- Dong Y, Mo XI, Hu Y, et al. Epidemiology of COVID‐19 among children in China. Pediatrics. 2020;145(6):e20200702. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
